The latest information technology infrastructure and communication tools should be used to communicate research without compromising nuances of the content for individual patients.
Daniel T. Leonard, MA
Advertisement
Articles by Daniel T. Leonard, MA
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
FDA Scrutiny of GLP-1 Compounding Is Just Getting Started, Expert Says
2
FDA Approves Veligrotug-vvze as First Agent With Data in Both Active and Chronic Thyroid Eye Disease
3
From Misnomer to Meaning: A Patient-Centered Shift from PCOS to PMOS
4
Menin Inhibitors in AML: Frequently Asked Questions
5